| Bioactivity | DS08210767 is a highly potent, orally bioavailable PTHR1 antagonist with IC50 of 90 nM[1]. | |||||||||
| Target | IC50: 90 nM (PTHR1) | |||||||||
| Name | DS08210767 | |||||||||
| CAS | 2376334-75-5 | |||||||||
| Formula | C31H39N5O2 | |||||||||
| Molar Mass | 513.67 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Arai Y, et al. Discovery of novel PTHR1 antagonists: Design, synthesis, and structure activity relationships. Bioorg Med Chem Lett. 2019 Sep 15;29(18):2613-2616. |